By Fatumina Said Abukar
This project focuses on using a design of experiment approach (DOE) to identify the critical quality attributes (CQAs) of cell therapy candidates. Current assays lack in robustness and reproducibility. We aim to develop standardized assays that can be used as a first screen platform for cell therapy products in clinical applications and at industrial scale.
This project focuses on using a design of experiment approach (DOE) to identify the critical quality attributes (CQAs) of cell therapy candidates. Current assays lack in robustness and reproducibility. We aim to develop standardized assays that can be used as a first screen platform for cell therapy products in clinical applications and at industrial scale.